A sixth dose of tetanus, diphtheria, acellular pertussis (Tdap) vaccine in adolescents might
produce a differing reactogenicity and/or immunogenicity response depending on the …

Pertussis is increasingly being recognized as an important cause of cough illness in
adolescents and adults. To evaluate the safety and immunogenicity of an adult formulation …

The effect of injection site on reactogenicity and specific immunogenicity was assessed in
participants in a pertussis vaccine efficacy trial. The percent of DTwP and DTaP recipients …

Acellular pertussis vaccines have been used for mass immunization of children in Japan
since the fall of 1981, but until recently they have not been evaluated in the United States …

The aim of this study was to compare pertussis-specific humoral and cellular immunity in
children 5 years after a primary vaccination with a combined diphtheria, tetanus …

Objective. To evaluate the immunogenicity and reactogenicity of an acellular pertussis
vaccine (pa) either formulated with diphtheria and tetanus toxoids (dTpa) or administered …

In a multicenter, double-blind, randomized, longitudinal study, 252 children recelved
licensed Lederie diphtheria-tetanus toxoids and pertussis vaccine adsorbed (DTP) at 2, 4 …

Universal vaccination of neonates and children against diphtheria, tetanus and pertussis
has had a tremendous impact on the control of these infectious diseases worldwide …

Background: Safety of a sixth consecutive dose of acellular pertussis vaccine in adolescents
was assessed in a 2-armed, randomized study. Methods: Adolescents who had received 5 …

An acellular pertussis vaccine (DTaP) containing pertussis toxoid, filamentous
hemagglutinin and the 69-kDa outer membrane protein (pertactin) was compared with …